SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General statement of acquisition of beneficial ownership:
SEC Accession No. 0000950142-20-001798
Filing Date
2020-07-27
Accepted
2020-07-27 16:16:03
Documents
1
Group Members
GLENVIEW CAPITAL MANAGEMENT, LLCLAWRENCE M. ROBBINS

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13D eh2000964_13d-bausch.htm SC 13D 124931
  Complete submission text file 0000950142-20-001798.txt   126963
Mailing Address 2150 ST. ELZEAR BLVD. WEST LAVAL QUEBEC A8 H7L 4A8
Business Address 2150 ST. ELZEAR BLVD. WEST LAVAL QUEBEC A8 H7L 4A8 514-744-6792
Bausch Health Companies Inc. (Subject) CIK: 0000885590 (see all company filings)

IRS No.: 000000000 | State of Incorp.: NJ | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-45947 | Film No.: 201050614
SIC: 2834 Pharmaceutical Preparations

Mailing Address 767 FIFTH AVENUE 44TH FLOOR NEW YORK NY 10153
Business Address 767 FIFTH AVENUE 44TH FLOOR NEW YORK NY 10153 2128124700
GLENVIEW CAPITAL MANAGEMENT, LLC (Filed by) CIK: 0001138995 (see all company filings)

IRS No.: 134136746 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D